AXSOME THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
AXSOME THERAPEUTICS, INC. (AXSM) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 5.90 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-10
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 5.90M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 6.62M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 7.03M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 7.59M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 5.90M shares 10-Q · filed 2026-08-10 | |
| 2026-03-31 | 6.62M shares 10-Q · filed 2026-05-04 | |
| 2025-12-31 | 7.03M shares 10-Q · filed 2026-08-10 | |
| 2025-09-30 | 7.59M shares 10-Q · filed 2025-11-03 | |
| 2025-06-30 | 8.09M shares 10-Q · filed 2025-08-04 | |
| 2025-03-31 | 8.29M shares 10-Q · filed 2025-05-05 | |
| 2024-12-31 | 8.44M shares 10-K · filed 2026-02-23 | |
| 2024-09-30 | 8.45M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 8.94M shares 10-Q · filed 2024-08-05 | |
| 2024-03-31 | 9.16M shares 10-Q · filed 2024-05-06 | |
| 2023-12-31 | 8.46M shares 10-K · filed 2025-02-18 | |
| 2023-09-30 | 8.15M shares 10-Q · filed 2023-11-06 | |
| 2023-06-30 | 7.93M shares 10-Q · filed 2023-08-07 | |
| 2023-03-31 | 8.04M shares 10-Q · filed 2023-05-09 | |
| 2022-12-31 | 6.62M shares 10-K · filed 2024-02-23 | |
| 2022-09-30 | 6.54M shares 10-Q · filed 2022-11-07 | |
| 2022-06-30 | 6.52M shares 10-Q · filed 2022-08-09 | |
| 2022-03-31 | 6.22M shares 10-Q · filed 2022-05-02 | |
| 2021-12-31 | 5.09M shares 10-K · filed 2023-02-28 | |
| 2021-09-30 | 4.59M shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 4.46M shares 10-Q · filed 2021-08-09 | |
| 2021-03-31 | 4.39M shares 10-Q · filed 2021-05-10 | |
| 2020-12-31 | 3.73M shares 10-K · filed 2022-03-01 | 3.73M shares 10-K · filed 2021-03-01 |
| 2020-09-30 | 3.91M shares 10-Q · filed 2020-11-05 | |
| 2020-06-30 | 3.98M shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 3.96M shares 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 3.46M shares 10-K · filed 2021-03-01 | |
| 2019-09-30 | 3.18M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 3.11M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 3.10M shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 2.28M shares 10-K · filed 2020-03-12 | 2.29M shares 10-K · filed 2019-03-15 |
| 2018-09-30 | 2.76M shares 10-Q · filed 2018-11-09 | |
| 2018-06-30 | 2.91M shares 10-Q · filed 2018-08-08 | |
| 2018-03-31 | 2.76M shares 10-Q · filed 2018-05-08 | |
| 2017-12-31 | 2.32M shares 10-K · filed 2019-03-15 | |
| 2017-09-30 | 2.34M shares 10-Q · filed 2017-11-08 | |
| 2017-06-30 | 2.17M shares 10-Q · filed 2017-08-09 | |
| 2017-03-31 | 2.14M shares 10-Q · filed 2017-05-09 | |
| 2016-12-31 | 1.77M shares 10-K · filed 2018-03-07 | |
| 2016-09-30 | 1.78M shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 1.76M shares 10-Q · filed 2016-08-09 | |
| 2016-03-31 | 998.20K shares 10-Q/A · filed 2016-08-09 | |
| 2015-12-31 | 998.20K shares 10-K · filed 2017-03-07 | |
| 2014-12-31 | 705.90K shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |